Intranasal Oxytocin for ObesityFranziska Plessow, Elizabeth A. Lawson, Madhusmita Misra et al.|NEJM Evidence|2024Cited by 20
A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methodsMarie‐Louis Wronski, Elizabeth A. Lawson, Franziska Plessow et al.|Contemporary Clinical Trials|2022Cited by 13
THU115 Sex-Specific And Shared Associations Between Vasopressin Levels And Body Composition In Adults With ObesityFrancesca Galbiati, Elizabeth A. Lawson, Marie‐Louis Wronski et al.|Journal of the Endocrine Society|2023Cited by 0
Corrigendum to “A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods” [Contemporary Clinical Trials 122 (2022) 1-11/106909]Marie‐Louis Wronski, Elizabeth A. Lawson, Franziska Plessow et al.|Contemporary Clinical Trials|2024Cited by 0